Combination Therapy Holds Promise for Advanced Prostate Cancer Treatment

A combination of decitabine that targets loss of the gene RB1 and DS-7300a that targets the B7-H3 receptors effectively reduces advanced prostate tumor growth.

Related Keywords

,Prostate Cancer ,Prostate Tumor ,Prostate Cancer Treatment ,Combination Therapy ,Na Methylation ,